#3421 on the rich list of 14,644 insiders
R.A. Session II
10% owner at Taysha Gene Therapies. Based in Dallas, Texas.
$34.0M
in disclosed stock, −$2.0M (−5.51%) today
Market closed. Prices as of Nov 19, 4:04 PM ET
- Rank
- 3421st of 14,644
- Companies held
- 1
- Largest holding
- TSHA, 100.0% of total
- Latest SEC filing
- Jul 13, 2023
What the $34.0M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Taysha Gene Therapies TSHA Common Stock | Directly | 8,871,747 | $3.77 | $33.4M | 98.4% | Form 4, Jul 13, 2023 |
| Taysha Gene Therapies TSHA Common Stock | Through Session 2020 Annuity Trust | 141,090 | $3.77 | $532K | 1.6% | Form 4, Jul 12, 2023 |
Share counts are the amounts R.A. Session II reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 3418 | Douglas A. Robinson Co-President, Workday. San Francisco, CA | $34.0M |
| 3419 | Michele Buck Chairman, President and CEO, The Hershey. New York, NY | $34.0M |
| 3420 | Roger A. Baker Director, HBT Financial. Bloomington, IL | $34.0M |
| 3421 | R.A. Session II 10% owner, Taysha Gene Therapies. Dallas, TX | $34.0M |
| 3422 | Emily Reuter CHIEF FINANCIAL OFFICER, Maplebear. San Francisco, CA | $34.0M |
| 3423 | Brent L. Saunders Chairman of the Board and CEO, Bausch + Lomb | $34.0M |
| 3424 | James S. Kramer Executive Vice President, Astronics. East Aurora, NY | $34.0M |
Other Taysha Gene Therapies insiders
All TSHA insiders- Paul B. Manning$86.4M10% owner. #663 overall
- Sean P. Nolan$16.8MChief Executive Officer. #5403 overall
- John A. Stalfort III$7.8MDirector. #10055 overall
- Kamran Alam$5.4MCHIEF FINANCIAL OFFICER. #13647 overall
Questions
How much stock does R.A. Session II own?
R.A. Session II holds $33,978,395 in listed stock based on SEC filings and current prices, mostly Taysha Gene Therapies (TSHA). That ranks 3421st on the Stock Rich List.
Is this R.A. Session II's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.